Tansna Therapeutics tansna.com


Public list: Pharma Startups (6570) Neuroscience Startups (947)

Tansna Therapeutics is a drug discovery and development company focused on novel therapies for the treatment of CNS disorders, with an initial focus on epilepsy. The company has identified a library of proprietary compounds that are derivatives of the marketed anesthetic propofol. These compounds are drug-like small-molecules, exhibit broad-spectrum CNS pharmacology, and are non-sedating.

Tansna Therapeutics is a drug discovery and development company focused on novel therapies for the treatment of CNS disorders, with an initial focus on epilepsy. The company has identified a library of proprietary compounds that are derivatives of th...Show all

Company (Alive / Active)

Phone:

Fax:

4320 Forest Park Avenue
Suite 303
St. Louis, 63108
Missouri, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Tansna Therapeutics $0.9M Mar 5, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Tansna Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
2,5-dialkyl-4-h/halo/ether-phenol compounds Nov 24, 2014 Apr 25, 2017 Patent
2,5-dialkyl-4-h/halo/ether-phenol compounds Feb 27, 2017 Application